Emcure Pharmaceuticals Ltd.
EMCURE
Classement en actions
#4335
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Prix de l'action
$18.81
Capitalisation boursière
$3.57B
Changement (1 jour)
-3.13%
Changement (1 an)
18.91%
Pays
IN
Échange Emcure Pharmaceuticals Ltd. (EMCURE)
Catégorie
Healthcare
Historique du prix de l'action pour Emcure Pharmaceuticals Ltd. (EMCURE)
Prix de clôture le plus élevé : $20.40 le 2026-10-01
Prix de clôture le plus bas : $15.91 le 2024-07-01
Prix de clôture le plus bas : $15.91 le 2024-07-01
Historique du prix de l'action de Emcure Pharmaceuticals Ltd. de 2024 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 16.96% |
| 2025 | -4.84% |
| 2024 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
